PFM
Privium Fund Management Portfolio holdings
AUM
$464M
This Quarter Return
-2.39%
1 Year Return
+124.83%
3 Year Return
+508.69%
5 Year Return
–
10 Year Return
–
AUM
$384M
AUM Growth
+$384M
(-13%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
77.1%
Holding
69
New
5
Increased
21
Reduced
13
Closed
13
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$5.47M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$4.02M |
| 3 |
Arrowhead Research
ARWR
|
$3.17M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$1.54M |
| 5 |
Immunovant
IMVT
|
$1.23M |
Top Sells
Sector Composition
| 1 | Consumer Discretionary | 29.62% |
| 2 | Technology | 24.05% |
| 3 | Healthcare | 23.5% |
| 4 | Communication Services | 20.98% |
| 5 | Energy | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Spotify
SPOT
$140B
| $80.5M | 20.98% | 145,000 | – | – |
|
2
Tesla
TSLA
$1.08T
| $57.4M | 14.96% | 220,000 | – | – |
|
3
Shopify
SHOP
$184B
| $39.8M | 10.38% | 415,000 | – | – |
|
4
Palantir
PLTR
$372B
| $30.6M | 7.98% | 360,000 -10,000 | -3% | -$850K |
|
5
Sea Limited
SE
$110B
| $27.4M | 7.15% | 210,000 | – | – |
|
6
Amazon
AMZN
$2.44T
| $27M | 7.03% | 141,000 | – | – |
|
7
Ultragenyx Pharmaceutical
RARE
$2.89B
| $9.05M | 2.36% | 249,804 -8,576 | -3% | -$311K |
|
8
Ionis Pharmaceuticals
IONS
$6.8B
| $8.07M | 2.1% | 267,594 +800 | +0.3% | +$24.1K |
|
|
9
Arrowhead Research
ARWR
$3.05B
| $8.02M | 2.09% | 629,214 +248,628 | +65% | +$3.17M |
|
10
NVIDIA
NVDA
$4.24T
| $7.93M | 2.07% | 73,000 | – | – |
|
11
Snowflake
SNOW
$79.6B
| $7.13M | 1.86% | 48,000 -27,000 | -36% | -$4.01M |
|
12
Cloudflare
NET
$72.7B
| $6.76M | 1.76% | 60,000 | – | – |
|
13
ProQR Therapeutics
PRQR
$237M
| $6.63M | 1.73% | 4,985,633 | – | – |
|
14
Axsome Therapeutics
AXSM
$6.05B
| $6.15M | 1.6% | 52,732 -9,500 | -15% | -$1.11M |
|
15
uniQure
QURE
$896M
| $6.14M | 1.6% | 579,139 -163,023 | -22% | -$1.73M |
|
|
SWTX
16
DELISTED
SpringWorks Therapeutics
SWTX
| $5.47M | 1.43% | +123,980 | New | +$5.47M |
|
17
Arcutis Biotherapeutics
ARQT
$1.86B
| $5.09M | 1.33% | 325,709 | – | – |
|
18
Zai Lab
ZLAB
$3.68B
| $4.78M | 1.25% | 132,189 -52,873 | -29% | -$1.91M |
|
|
19
Vertex Pharmaceuticals
VRTX
$100B
| $4.02M | 1.05% | +8,300 | New | +$4.02M |
|
20
Merck
MRK
$210B
| $3.69M | 0.96% | 41,093 -31,518 | -43% | -$2.83M |
|
21
Rocket Pharmaceuticals
RCKT
$354M
| $2.89M | 0.75% | 432,760 +35,110 | +9% | +$234K |
|
22
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.46M | 0.64% | 148,400 | – | – |
|
23
Moderna
MRNA
$9.37B
| $2.14M | 0.56% | 75,576 -6,900 | -8% | -$196K |
|
24
CRISPR Therapeutics
CRSP
$4.71B
| $2.05M | 0.53% | 60,097 +25,100 | +72% | +$854K |
|
25
Ambev
ABEV
$34.9B
| $1.87M | 0.49% | 804,206 +151,849 | +23% | +$354K |
|